Scarica l'app Stockscreener
34.91
2.74%
0.93
Precedente Chiudi:
$33.98
Aprire:
$33.63
Volume 24 ore:
84,238
Relative Volume:
0.44
Capitalizzazione di mercato:
$682.47M
Reddito:
-
Utile/perdita netta:
$-83.49M
Rapporto P/E:
-7.8326
EPS:
-4.457
Flusso di cassa netto:
$-60.29M
1 W Prestazione:
+12.69%
1M Prestazione:
+0.29%
6M Prestazione:
+56.69%
1 anno Prestazione:
+42.66%
Intervallo 1D:
$33.32
$35.02
Intervallo di 1 settimana:
$30.00
$37.40
Portata 52W:
$14.38
$39.53
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Nome
Tectonic Therapeutic Inc
Settore
Industria
Telefono
(339) 666-3320
Indirizzo
490 ARSENAL WAY, WATERTOWN
Compare TECX vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
34.91 | 720.00M | 0 | -83.49M | -60.29M | -4.457 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-05-26 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2026-04-14 | Iniziato | Stifel | Buy |
| 2025-10-20 | Iniziato | Wells Fargo | Overweight |
| 2025-09-03 | Iniziato | Oppenheimer | Outperform |
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-06-11 | Ripresa | Raymond James | Outperform |
| 2025-04-21 | Iniziato | Mizuho | Outperform |
| 2024-11-20 | Iniziato | Raymond James | Outperform |
| 2024-08-22 | Iniziato | Wells Fargo | Overweight |
| 2024-06-26 | Iniziato | Piper Sandler | Overweight |
| 2024-06-24 | Iniziato | TD Cowen | Buy |
| 2023-12-18 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-05 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-11-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | Iniziato | BTIG Research | Buy |
| 2021-05-27 | Iniziato | Needham | Buy |
| 2021-03-09 | Iniziato | Barclays | Overweight |
| 2021-03-02 | Iniziato | Stifel | Hold |
| 2020-11-11 | Iniziato | Berenberg | Buy |
| 2020-03-31 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | Iniziato | Mizuho | Buy |
| 2019-04-05 | Iniziato | Janney | Buy |
| 2018-10-10 | Iniziato | Guggenheim | Buy |
| 2018-10-02 | Reiterato | H.C. Wainwright | Buy |
| 2018-09-17 | Iniziato | H.C. Wainwright | Buy |
| 2018-07-16 | Iniziato | Wedbush | Outperform |
| 2018-07-16 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Tectonic Therapeutic Inc Borsa (TECX) Ultime notizie
Tectonic Therapeutic CSO McNamara sells $1,505 in shares By Investing.com - Investing.com India
Tectonic Therapeutic CSO McNamara sells $1,505 in shares - Investing.com
TECX (TECX) insider plans 129-share sale and notes prior 10b5-1 trade - Stock Titan
Tectonic Therapeutic (NASDAQ:TECX) Trading Up 13.3%Here's What Happened - marketbeat.com
Wells Fargo Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Cuts Target Price to $93 - Moomoo
Tectonic Therapeutic (NASDAQ:TECX) Upgraded by Wall Street Zen to "Sell" Rating - marketbeat.com
Tectonic Therapeutic (NASDAQ:TECX) Announces Earnings Results, Beats Estimates By $0.17 EPS - marketbeat.com
TECX Maintained by Wells Fargo -- Price Target Lowered to $93.00 - GuruFocus
Piper Sandler Maintains Tectonic Therapeutic(TECX.US) With Buy Rating, Maintains Target Price $76 - Moomoo
Wells Fargo & Company Issues Pessimistic Forecast for Tectonic Therapeutic (NASDAQ:TECX) Stock Price - marketbeat.com
Tectonic Therapeutic, Inc. (TECX) Investor Outlook: Exploring A 159.58% Potential Upside - DirectorsTalk Interviews
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Consensus Rating of "Moderate Buy" from Brokerages - marketbeat.com
Tectonic Therapeutic, Inc. Stock 12‑Month Price Target Cut to $77.56, Implies 157% Upside - TradingView
Tectonic Therapeutic Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Tectonic Therapeutic, Inc. 2Q 2026: Net loss $22.3M, EPS $(1.18) — 10-Q Summary - TradingView
TECX: TX45 Phase 2 trial enrollment completed; topline results expected Q1 2027 - TradingView
Tectonic Therapeutic reports Q2 net loss $22.3M, cash $227.1M; TX45 enrollment complete - TradingView
Press Release: Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights - Moomoo
Tectonic Therapeutic (TECX) Earnings Date and Reports 2026 - marketbeat.com
TECX,RNAC Options - Finviz
Tectonic Therapeutic Inc (TECX) Valuation: PE, PB & Fair Value Analysis - TradingKey
TECX|Tectonic Therapeutic Inc|Price:30.370|Chg%:-1.240 - TradingKey
Tectonic Therapeutic Inc (TECX) Cash Flow - tradingkey.com
TECX|Tectonic Therapeutic Inc|Price:30.590|Chg%:+0.220 - TradingKey
Orbimed Advisors LLC Has $7 Million Stock Position in Tectonic Therapeutic, Inc. $TECX - marketbeat.com
Tectonic Therapeutic Inc (TECX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tectonic Therapeutic Inc (TECX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Tectonic Therapeutic Inc (TECX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tectonic Therapeutic Inc (TECX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Tectonic Therapeutic, Inc. Revenue Breakdown – NASDAQ:TECX - TradingView
Tectonic Therapeutic Inc (TECX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Tectonic Therapeutic Inc (TECX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
Tectonic Therapeutic Inc (TECX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Price to book forward of Tectonic Therapeutic, Inc. – NASDAQ:TECX - TradingView
Tectonic Therapeutic, Inc. (NASDAQ: TECX) Share Price, TECX Stock News, TECX Share Price & Updates - Kalkine
Tectonic Therapeutic (NASDAQ:TECX) Stock Rating Lowered by Zacks Research - marketbeat.com
Tectonic Therapeutic (NASDAQ:TECX) Stock Price Down 4.4%Time to Sell? - MarketBeat
TECX Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues R&D InvestmentNet Income Trends - dars.gov.et
Enterprise value to revenue forward of Tectonic Therapeutic, Inc. – BOATS:TECX - TradingView
Price to earnings forward of Tectonic Therapeutic, Inc. – BOATS:TECX - TradingView
Price to sales forward of Tectonic Therapeutic, Inc. – BOATS:TECX - TradingView
Here's Why We're Not Too Worried About Tectonic Therapeutic's (NASDAQ:TECX) Cash Burn Situation - Moomoo
MSN Money - MSN
If You Invested $1,000 in Tectonic Therapeutic Inc (TECX) - Stock Titan
achievement unlocked! - Moomoo
Tectonic Therapeutic (TECX) CSO exercises options and sells 172 shares under 10b5-1 plan - Stock Titan
Form 144 TECTONIC THERAPEUTIC For: 30 June By Investing.com - Investing.com Nigeria
[144] Tectonic Therapeutic, Inc. SEC Filing - Stock Titan
Tectonic Therapeutic (TECX) Stages a 3% Rally: Key Levels to Watch for Continued MomentumEnding Diagonal - dars.gov.et
Tectonic Therapeutic Inc Actuals & Estimates (NASDAQ:TECX) - TradingView
Tectonic Therapeutic Inc Azioni (TECX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):